Our range of products
Our range of products
Explore our diverse range of high-quality products, developed to meet your unique needs while ensuring superior efficacy and reliability
Bio-pharmaceuticals and Generics
Bio-pharmaceuticals and Generics
Bio-pharmaceuticals and Generics
We specialize in Bio-pharmaceuticals and Generics — innovative medicines from living cells and affordable alternatives to brand-name drugs. Our mission is to make high-quality treatments accessible to all, combining advanced science with affordability to improve health outcomes.
We specialize in Bio-pharmaceuticals and Generics — innovative medicines from living cells and affordable alternatives to brand-name drugs. Our mission is to make high-quality treatments accessible to all, combining advanced science with affordability to improve health outcomes.
We specialize in Bio-pharmaceuticals and Generics — innovative medicines from living cells and affordable alternatives to brand-name drugs. Our mission is to make high-quality treatments accessible to all, combining advanced science with affordability to improve health outcomes.
Liraglutide (API)
Our high-purity GLP-1 receptor agonist, Liraglutide, is designed for the effective management of type 2 diabetes and obesity. Manufactured under stringent GMP conditions, it ensures global compliance, exceptional purity, and consistent quality. With its proven efficacy, Liraglutide supports both therapeutic applications and advanced research. Trusted by healthcare professionals and researchers worldwide, it meets the highest standards of safety, stability, and performance.
Learn more
Liraglutide (API)
Our high-purity GLP-1 receptor agonist, Liraglutide, is designed for the effective management of type 2 diabetes and obesity. Manufactured under stringent GMP conditions, it ensures global compliance, exceptional purity, and consistent quality. With its proven efficacy, Liraglutide supports both therapeutic applications and advanced research. Trusted by healthcare professionals and researchers worldwide, it meets the highest standards of safety, stability, and performance.
Learn more
Liraglutide (API)
Our high-purity GLP-1 receptor agonist, Liraglutide, is designed for the effective management of type 2 diabetes and obesity. Manufactured under stringent GMP conditions, it ensures global compliance, exceptional purity, and consistent quality. With its proven efficacy, Liraglutide supports both therapeutic applications and advanced research. Trusted by healthcare professionals and researchers worldwide, it meets the highest standards of safety, stability, and performance.
Learn more
Semaglutide (API)
A cutting-edge GLP-1 receptor agonist, Semaglutide is a breakthrough in diabetes and weight management. With its high binding affinity and extended half-life, it effectively regulates blood sugar levels while promoting significant weight loss. Manufactured under stringent GMP guidelines, our Semaglutide guarantees exceptional purity, stability, and consistency. Backed by extensive research and clinical validation, it offers superior efficacy and safety.
Learn more
Semaglutide (API)
A cutting-edge GLP-1 receptor agonist, Semaglutide is a breakthrough in diabetes and weight management. With its high binding affinity and extended half-life, it effectively regulates blood sugar levels while promoting significant weight loss. Manufactured under stringent GMP guidelines, our Semaglutide guarantees exceptional purity, stability, and consistency. Backed by extensive research and clinical validation, it offers superior efficacy and safety.
Learn more
Semaglutide (API)
A cutting-edge GLP-1 receptor agonist, Semaglutide is a breakthrough in diabetes and weight management. With its high binding affinity and extended half-life, it effectively regulates blood sugar levels while promoting significant weight loss. Manufactured under stringent GMP guidelines, our Semaglutide guarantees exceptional purity, stability, and consistency. Backed by extensive research and clinical validation, it offers superior efficacy and safety.
Learn more
Parathyroid Hormone (PTH) (API)
Our recombinant Parathyroid Hormone (PTH) API is a vital therapeutic agent for osteoporosis and hypoparathyroidism management. Engineered to mimic endogenous PTH, it plays a crucial role in calcium and phosphate homeostasis, enhancing bone formation and mineral density. With ≥98% purity and high bioactivity, our PTH is manufactured under cGMP standards, ensuring consistency, stability, and regulatory compliance. it is available in scalable bulk quantities.
Learn more
Parathyroid Hormone (PTH) (API)
Our recombinant Parathyroid Hormone (PTH) API is a vital therapeutic agent for osteoporosis and hypoparathyroidism management. Engineered to mimic endogenous PTH, it plays a crucial role in calcium and phosphate homeostasis, enhancing bone formation and mineral density. With ≥98% purity and high bioactivity, our PTH is manufactured under cGMP standards, ensuring consistency, stability, and regulatory compliance. it is available in scalable bulk quantities.
Learn more
Parathyroid Hormone (PTH) (API)
Our recombinant Parathyroid Hormone (PTH) API is a vital therapeutic agent for osteoporosis and hypoparathyroidism management. Engineered to mimic endogenous PTH, it plays a crucial role in calcium and phosphate homeostasis, enhancing bone formation and mineral density. With ≥98% purity and high bioactivity, our PTH is manufactured under cGMP standards, ensuring consistency, stability, and regulatory compliance. it is available in scalable bulk quantities.
Learn more
Recombinant Human Albumin (API)
Our animal-free Recombinant Human Albumin (rHA) is produced using advanced recombinant DNA technology to achieve exceptional purity and consistency. Designed to support biopharmaceutical applications, regenerative medicine, diagnostics, and drug formulation, rHA offers a safer and more reliable alternative to plasma-derived albumin. Manufactured under stringent GMP conditions, it ensures stability, reduced variability, and high binding capacity.
Learn more
Recombinant Human Albumin (API)
Our animal-free Recombinant Human Albumin (rHA) is produced using advanced recombinant DNA technology to achieve exceptional purity and consistency. Designed to support biopharmaceutical applications, regenerative medicine, diagnostics, and drug formulation, rHA offers a safer and more reliable alternative to plasma-derived albumin. Manufactured under stringent GMP conditions, it ensures stability, reduced variability, and high binding capacity.
Learn more
Recombinant Human Albumin (API)
Our animal-free Recombinant Human Albumin (rHA) is produced using advanced recombinant DNA technology to achieve exceptional purity and consistency. Designed to support biopharmaceutical applications, regenerative medicine, diagnostics, and drug formulation, rHA offers a safer and more reliable alternative to plasma-derived albumin. Manufactured under stringent GMP conditions, it ensures stability, reduced variability, and high binding capacity.
Learn more
Ranibizumab (API)
Ranibizumab is a recombinant monoclonal antibody fragment (Fab) specifically engineered to target vascular endothelial growth factor A (VEGF-A). Widely used for the treatment of retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), Ranibizumab effectively inhibits abnormal blood vessel growth and leakage. Our API is produced under strict GMP conditions, ensuring outstanding purity, and bioactivity.
Learn more
Ranibizumab (API)
Ranibizumab is a recombinant monoclonal antibody fragment (Fab) specifically engineered to target vascular endothelial growth factor A (VEGF-A). Widely used for the treatment of retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), Ranibizumab effectively inhibits abnormal blood vessel growth and leakage. Our API is produced under strict GMP conditions, ensuring outstanding purity, and bioactivity.
Learn more
Ranibizumab (API)
Ranibizumab is a recombinant monoclonal antibody fragment (Fab) specifically engineered to target vascular endothelial growth factor A (VEGF-A). Widely used for the treatment of retinal diseases such as age-related macular degeneration (AMD) and diabetic macular edema (DME), Ranibizumab effectively inhibits abnormal blood vessel growth and leakage. Our API is produced under strict GMP conditions, ensuring outstanding purity, and bioactivity.
Learn more
Human Growth Hormone (API)
Recombinant Human Growth Hormone (HGH) is a critical biopharmaceutical used in the treatment of growth disorders, metabolic dysfunctions, and age-related conditions. Engineered for optimal bioactivity, our HGH API boasts >98% purity and is manufactured under cGMP regulations to ensure consistency, efficacy, and safety. Designed for pharmaceutical and therapeutic applications, it promotes cell regeneration, muscle growth, and overall metabolic health.
Learn more
Human Growth Hormone (API)
Recombinant Human Growth Hormone (HGH) is a critical biopharmaceutical used in the treatment of growth disorders, metabolic dysfunctions, and age-related conditions. Engineered for optimal bioactivity, our HGH API boasts >98% purity and is manufactured under cGMP regulations to ensure consistency, efficacy, and safety. Designed for pharmaceutical and therapeutic applications, it promotes cell regeneration, muscle growth, and overall metabolic health.
Learn more
Human Growth Hormone (API)
Recombinant Human Growth Hormone (HGH) is a critical biopharmaceutical used in the treatment of growth disorders, metabolic dysfunctions, and age-related conditions. Engineered for optimal bioactivity, our HGH API boasts >98% purity and is manufactured under cGMP regulations to ensure consistency, efficacy, and safety. Designed for pharmaceutical and therapeutic applications, it promotes cell regeneration, muscle growth, and overall metabolic health.
Learn more
L-Asparaginase (API)
L-Asparaginase is a crucial enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL) and as a processing aid in the food industry. Produced via advanced bacterial fermentation, our API ensures ≥97% purity and optimal enzymatic activity. Under stringent GMP compliance, it maintains excellent stability, bioavailability, and batch-to-batch consistency. With a proven safety and efficacy profile, our L-Asparaginase supports pharmaceutical and industrial applications.
Learn more
L-Asparaginase (API)
L-Asparaginase is a crucial enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL) and as a processing aid in the food industry. Produced via advanced bacterial fermentation, our API ensures ≥97% purity and optimal enzymatic activity. Under stringent GMP compliance, it maintains excellent stability, bioavailability, and batch-to-batch consistency. With a proven safety and efficacy profile, our L-Asparaginase supports pharmaceutical and industrial applications.
Learn more
L-Asparaginase (API)
L-Asparaginase is a crucial enzyme widely used in the treatment of acute lymphoblastic leukemia (ALL) and as a processing aid in the food industry. Produced via advanced bacterial fermentation, our API ensures ≥97% purity and optimal enzymatic activity. Under stringent GMP compliance, it maintains excellent stability, bioavailability, and batch-to-batch consistency. With a proven safety and efficacy profile, our L-Asparaginase supports pharmaceutical and industrial applications.
Learn more
PEG-Asparaginase (API)
PEG-Asparaginase is a PEGylated form of L-Asparaginase designed to enhance stability, prolong half-life, and reduce immunogenicity. Widely used in the treatment of acute lymphoblastic leukemia (ALL), it offers improved pharmacokinetics and a more favorable safety profile. Manufactured under stringent GMP guidelines, our PEG-Asparaginase ensures high enzymatic activity, reduced hypersensitivity reactions, and superior therapeutic performance.
Learn more
PEG-Asparaginase (API)
PEG-Asparaginase is a PEGylated form of L-Asparaginase designed to enhance stability, prolong half-life, and reduce immunogenicity. Widely used in the treatment of acute lymphoblastic leukemia (ALL), it offers improved pharmacokinetics and a more favorable safety profile. Manufactured under stringent GMP guidelines, our PEG-Asparaginase ensures high enzymatic activity, reduced hypersensitivity reactions, and superior therapeutic performance.
Learn more
PEG-Asparaginase (API)
PEG-Asparaginase is a PEGylated form of L-Asparaginase designed to enhance stability, prolong half-life, and reduce immunogenicity. Widely used in the treatment of acute lymphoblastic leukemia (ALL), it offers improved pharmacokinetics and a more favorable safety profile. Manufactured under stringent GMP guidelines, our PEG-Asparaginase ensures high enzymatic activity, reduced hypersensitivity reactions, and superior therapeutic performance.
Learn more
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
OUR TRUSTED PARTNERS
Empowering discovery through effective partnerships
Lorven biologics
Innovating today for a better tomorrow
Innovating today for a better tomorrow
Innovating today for a better tomorrow
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Shaping the future of global health through biotech innovation. Partner with Lorven Biologics to advance affordable, high-quality healthcare solutions. Let’s collaborate and create lasting impact.
Based in Hyderabad, IN
Based in Hyderabad, IN
Based in Hyderabad, IN
© 2025 Lorven Biologics. All Rights Reserved.
Empowering Science, Enriching Lives.
Explore More Products
Explore More Products